Welcome to LookChem.com Sign In|Join Free
  • or
valilactone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

113276-96-3

Post Buying Request

113276-96-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

113276-96-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 113276-96-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,2,7 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 113276-96:
(8*1)+(7*1)+(6*3)+(5*2)+(4*7)+(3*6)+(2*9)+(1*6)=113
113 % 10 = 3
So 113276-96-3 is a valid CAS Registry Number.
InChI:InChI=1/C22H39NO5/c1-5-7-9-11-13-18-19(28-21(18)25)14-17(12-10-8-6-2)27-22(26)20(16(3)4)23-15-24/h15-20H,5-14H2,1-4H3,(H,23,24)/t17-,18-,19-,20-/m0/s1

113276-96-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (-)-valilactone

1.2 Other means of identification

Product number -
Other names valilactone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:113276-96-3 SDS

113276-96-3Downstream Products

113276-96-3Related news

Synthesis of the β-lactone esterase inhibitor valilactone (cas 113276-96-3) using π-allyltricarbonyliron lactone complexes.08/12/2019

Synthesis of the esterase inhibitor valilactone (1) is reported employing the oxidation of π-allyltricarbonyliron lactone complexes with ceric ammonium nitrate to afford the inherent β-lactone ring.detailed

113276-96-3Relevant academic research and scientific papers

Synthesis of the β-lactone esterase inhibitor valilactone using πallyltricarbonyliron lactone complexes

Bates, Roderick W.,Fernandez-Moro, Rosalina,Ley, Steven V.

, p. 2651 - 2654 (1991)

Synthesis of the esterase inhibitor valilactone (1) is reported employing the oxidation of π-allyltricarbonyliron lactone complexes with ceric ammonium nitrate to afford the inherent β-lactone ring.

Asymmetric synthesis of valilactone

Mineeva

, p. 100 - 104 (2014)

Total synthesis of (-)-valilactone, an efficient pancreatic lipase inhibitor, was accomplished with the use of Keck allylation in the key step of construction of the target carbon skeleton.

BETA-LACTONE COMPOUNDS

-

Page/Page column 21; 42, (2009/05/28)

The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof: wherein R is an alkyl group, and R1 comprises at least one moiety selected from a group consisting of an alkyl, an alkenyl, an aryl, a heterocycle, hydroxyl, ester, amido, aldehyde, and a halogen.

Asymmetric synthesis of tetrahydrolipstatin and valilactone

Case-Green, Stephen C.,Davies, Stephen G.,Roberts, Paul M.,Russell, Angela J.,Thomson, James E.

experimental part, p. 2620 - 2631 (2009/04/06)

The highly diastereoselective aldol reaction between acyl complexes of the iron chiral auxiliary [(η5-C5H5)Fe(CO)(PPh3)] and β-hydroxy aldehydes (obtained via a Noyori asymmetric hydrogenation), followed by a tandem oxidative decomplexation-cyclisation process gives access to β-substituted and α,β-disubstituted β-lactones in high ee. This methodology has been employed in the asymmetric syntheses of tetrahydrolipstatin and valilactone.

Total synthesis and comparative analysis of orlistat, valilactone, and a transposed orlistat derivative: Inhibitors of fatty acid synthase

Ma, Gil,Zancanella, Manuel,Oyola, Yatsandra,Richardson, Robyn D.,Smith, Jeffrey W.,Romo, Daniel

, p. 4497 - 4500 (2007/10/03)

Concise syntheses of orlistat (Xenical), a two-carbon transposed orlistat derivative, and valilactone are described that employ the tandem Mukaiyama aldol-lactonization (TMAL) process as a key step. This process allows facile modification of the α-side chain. Versatile strategies for modifying the δ-side chain are described, involving cuprate addition and olefin metathesis. Comparative antagonistic activity of these derivatives toward a recombinant form of the thioesterase domain of fatty acid synthase is reported along with comparative activity-based profiling.

An expeditious enantioselective total synthesis of valilactone

Wu, Yikang,Sun, Ya-Ping

, p. 5748 - 5751 (2007/10/03)

The title compound was synthesized through an expeditious route using Crimmins aldolization to establish the two key stereogenic centers and a hydroxyl group activation (HGA) protocol to construct the anti α,β-disubstituted β-lactone from the corresponding syn aldol.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 113276-96-3